This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chakraborty, T Articles by Olson, E N Search for Related Content PubMed PubMed Citation Articles by Chakraborty, T Articles by Olson, E N

 Previous Article  |  Next Article 

Mol Cell Biol. 1991 December; 11(12): 6103-6108

Domains outside of the DNA-binding domain impart target gene specificity to myogenin and MRF4.

Department of Biochemistry and Molecular Biology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

ABSTRACT

Myogenin and MRF4 belong to the MyoD family of muscle-specific transcription factors, which can activate myogenesis when introduced into nonmyogenic cells. These proteins share homology within a basic-helix-loop-helix motif that mediates DNA binding and dimerization, but they are divergent in their amino and carboxyl termini. Although myogenin and MRF4 bind the same sequence within the muscle creatine kinase enhancer, only myogenin efficiently transactivates this enhancer. By creating chimeras of myogenin and MRF4, we show that the specificities of these factors for transactivation of the muscle creatine kinase enhancer can be interchanged by swapping their amino and carboxyl termini. Within these chimeras, strong cooperation between the amino and carboxyl termini was observed. These findings suggest that myogenin and MRF4 discriminate between muscle-specific enhancers and that target gene specificity is determined by domains surrounding the basic-helix-loop-helix region.

This article has been cited by other articles:

• Glick, E., Leshkowitz, D., Walker, M. D. (2000). Transcription Factor BETA2 Acts Cooperatively with E2A and PDX1 to Activate the Insulin Gene Promoter. J. Biol. Chem. 275: 2199-2204 [Abstract] [Full Text]  
• Ridgeway, A. G., Wilton, S., Skerjanc, I. S. (2000). Myocyte Enhancer Factor 2C and Myogenin Up-regulate Each Other's Expression and Induce the Development of Skeletal Muscle in P19 Cells. J. Biol. Chem. 275: 41-46 [Abstract] [Full Text]  
• Rawls, A, Valdez, M., Zhang, W, Richardson, J, Klein, W., Olson, E. (1998). Overlapping functions of the myogenic bHLH genes MRF4 and MyoD revealed in double mutant mice. Development 125: 2349-2358 [Abstract]  
• Moss, J. B., Olson, E. N., Schwartz, R. J. (1996). The Myogenic Regulatory Factor MRF4 Represses the Cardiac alpha -Actin Promoter through a Negative-acting N-terminal Protein Domain. J. Biol. Chem. 271: 31688-31694 [Abstract] [Full Text]  
• Takeda, S.'i., North, D. L., Diagana, T., Miyagoe, Y., Lakich, M. M., Whalen, R. G. (1995). Myogenic Regulatory Factors Can Activate TATA-containing Promoter Elements via an E-Box Independent Mechanism. J. Biol. Chem. 270: 15664-15670 [Abstract] [Full Text]  
• Zhang, W, Behringer, R R, Olson, E N (1995). Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies.. Genes Dev. 9: 1388-1399 [Abstract]  
• Olson, E N, Klein, W H (1994). bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out.. Genes Dev. 8: 1-8  
• Hughes, S., Taylor, J., Tapscott, S., Gurley, C., Carter, W., Peterson, C. (1993). Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones. Development 118: 1137-1147 [Abstract]